蓝光滤过型人工晶状体植入后渗出性年龄相关性黄斑变性风险:基于非渗出性年龄相关性黄斑变性状态的人群研究
该全国性人群队列研究比较蓝光滤过型(BLF)与透明人工晶状体(IOL)植入后渗出性年龄相关性黄斑变性(AMD)的风险。BLF组21741例与透明IOL组56357例相比,10年累积发病率分别为1.8%与1.7%,调整后风险无显著差异(aHR 1.12,95%CI 0.96-1.30)。结论认为BLF IOL不降低渗出性AMD风险,无论有无非渗出性AMD病史。
要点
- BLF IOL组10年渗出性AMD累积发病率为1.8%,透明IOL组为1.7%。
- 调整Cox模型aHR 1.12(95%CI 0.96-1.30,P=.149),Fine-Gray模型aHR 1.15(95%CI 0.97-1.36,P=.120)。
- 按年龄、性别及非渗出性AMD病史分层,各亚组均未见BLF IOL的保护效应。
核心结论
- 在韩国人群中,白内障手术植入BLF IOL不降低渗出性AMD的发生风险,无论有无非渗出性AMD病史。
研究设计与样本
- 全国性、基于人群的队列研究,使用韩国国民健康保险共享服务(NHISS)数据库数据。
- 纳入2012年1月至2018年12月间接受白内障手术且一年内双眼植入同一类型IOL(BLF或透明)的个体。
- BLF IOL组21741例,透明IOL组56357例;采用Kaplan-Meier分析估计10年累积发病率,Cox比例风险模型和Fine-Gray模型计算调整风险比(aHR)及95%CI,调整年龄、性别、社会经济状况和系统性疾病。
- 另在按年龄、性别和索引日期日历年匹配的队列中重复分析。
主要发现
- BLF IOL组平均随访7.0±2.5年,透明IOL组6.7±2.5年(P=.069)。
- BLF IOL组10年渗出性AMD累积发病率为1.8%(95%CI 1.5%-2.0%),透明IOL组为1.7%(95%CI 1.5%-1.8%)。
- 每10万人年发病率BLF IOL组为162.8,透明IOL组为153.9。
- 调整Cox模型aHR 1.12(95%CI 0.96-1.30,P=.149),Fine-Gray模型aHR 1.15(95%CI 0.97-1.36,P=.120),均无显著差异。
- 按年龄、性别和非渗出性AMD病史分层,各亚组发病率相当,未见BLF IOL保护效应;匹配队列分析结果相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate whether blue light-filtering (BLF) intraocular lenses (IOLs) reduce the risk of exudative age-related macular degeneration (AMD). DESIGN: A nationwide, population-based cohort study using data from the Korean National Health Insurance Sharing Service (NHISS) database. PARTICIPANTS: Individuals who underwent cataract surgery and received the same type of IOL (BLF or clear) in both eyes within one year between January 2012 and December 2018. METHODS: Participants were categorized into BLF IOL or clear IOL groups, and the risk of exudative AMD was compared between the 2 groups. The 10-year cumulative incidence of exudative AMD was estimated using Kaplan-Meier analysis. Cox proportional hazard models and the Fine-Gray model were applied to calculate adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs), adjusting for age, sex, socioeconomic status, and systemic diseases. The same analysis was performed in the cohort matched by age, sex, and the calendar year of the index date. MAIN OUTCOME MEASURES: 10-year cumulative incidence, incidence rate, and HR for exudative AMD. RESULTS: A total of 21,741 individuals with BLF IOLs were compared to 56,357 individuals with clear IOLs. The mean follow-up duration was 7.0 ± 2.5 years in the BLF IOL group and 6.7 ± 2.5 years in the clear IOL group (P = .069). The 10-year cumulative incidence of exudative AMD was 1.8% (95% CI, 1.5%-2.0%) in the BLF IOL group and 1.7% (95% CI, 1.5%-1.8%) in the clear IOL group. The incidence rates per 100,000 person-years were 162.8 and 153.9 in the BLF IOL group and clear IOL groups, respectively, with no significant difference in the adjusted Cox model (aHR 1.12; 95% CI, 0.96-1.30; P = .149) and the Fine-Gray model (aHR 1.15; 95% CI, 0.97-1.36; P = .120). Subgroup analyses based on age, sex, and history of nonexudative AMD showed no protective effect of BLF IOLs, with comparable incidence rates across all subgroups. Similar results were observed in the matched cohort analysis. CONCLUSIONS: BLF IOL implantation in cataract surgery does not reduce the risk of developing exudative AMD in the South Korean population, regardless of a history of nonexudative AMD.
引用
- Kim JY, Kim S, Cho J, et al. Exudative AMD Risk Following Blue Light-Filtering IOL Implantation: A Population-Based Study According to Non-Exudative AMD Status. Am J Ophthalmol. 2025. PMID: 40659110. doi:10.1016/j.ajo.2025.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。